Real-Life Effectiveness and Tolerance of Baricitinib for the Treatment of Severe Alopecia Areata with 1-Year Follow-Up Data
ConclusionBaricitinib is effective in treating patients with alopecia areata, particularly for the patchy phenotype, but with a risk of relapse after discontinuation. Safety data are reassuring, with lipid changes being the most frequent adverse event.
Source: Dermatology and Therapy - Category: Dermatology Source Type: research
More News: Alopecia | Alopecia Areata | Belgium Health | Clinical Trials | Dermatology | Skin | Sodium Chloride | Study